modality
The theory of possibility and necessity; consistency can be cast as a kind of logical-possibility (modal) claim.
As defined in 137 | Justin Clarke-Doane on Mathematics, Morality, Objectivity, and Reality
Other definitions
The format or delivery mechanism of learning, such as online, mobile, or live video, which can change how well a person learns.
Thesis Driven Investing
Where it comes up · 5
- Moderna: The Software of Life5 claims
- RTW: Investing Across Healthcare3 claims
- Thesis Driven Investing2 claims
- The Magician’s Twin, with David Berlinski, Stephen Meyer, and James Orr | Uncommon Knowledge1 claim
- 137 | Justin Clarke-Doane on Mathematics, Morality, Objectivity, and Reality1 claim
Most important claims · 10 of 12Search all claims for “modality” →
- The first wave of protein drugs had a small set of obvious targets, such as diabetics missing insulin and children missing human growth hormone, so early leaders such as Genentech and Biogen captured them first.Moderna: The Software of Life
- Materialism as a research program fusing science and philosophy is unraveling because science cannot reduce or eliminate consciousness, mathematics, modality, or morality without cutting against fundamental intuitionsThe Magician’s Twin, with David Berlinski, Stephen Meyer, and James Orr | Uncommon Knowledge
- Even if one could eliminate all reference to mathematical entities (as Hartry Field attempts), nothing is gained epistemologically, because everyone still needs to talk about consistency — a logical-possibility claim of the form 'diamond P' — which carries exactly the same epistemological problem as arithmetic claims: there is no experiment or observation that tells you it is true, so you have merely traded beefed-up ontology for beefed-up ideology with identical knowledge difficulties.137 | Justin Clarke-Doane on Mathematics, Morality, Objectivity, and Reality
- The US has averaged about 40 novel drug approvals per year for a long time, last year hit an all-time record of 61, and just under a quarter of those came from new modalities.RTW: Investing Across Healthcare
- Early leaders in a therapy modality accumulate compounding advantages as each successful drug adds data and know-how, making it hard for competitors to catch up, as Genentech and Biogen did with protein drugs.Moderna: The Software of Life
- Nucleic acid drugs are the third wave in pharma after small molecules and protein drugs, and investors should move quickly into this area because it may produce successors to insulin.Moderna: The Software of Life
- Extrapolating from the drugs in current development, US novel approvals should keep setting records and could reach 80 to 100 per year within five to ten years, with up to half coming from new technologies, which Rod characterizes as the golden age of medicine discovery.RTW: Investing Across Healthcare
- The COVID vaccine established that RNA drugs work, opening the third era of therapeutics after small molecules and proteins, so that one more successful drug would make Moderna the obvious next Genentech.Moderna: The Software of Life
- Predictive indicators in drug development are constantly evolving because of the explosion of new modalities such as RNA, cell therapy, protein degraders, bispecifics, antibody drug conjugates, and radiopharmaceuticals, where learning is often by failing, while small molecules and antibodies have long track records.RTW: Investing Across Healthcare
- Moderna's head start in RNA drugs gives it an advantage in pursuing the low-hanging fruit of this modality, though many competitors will follow.Moderna: The Software of Life